ACT's Chief Scientific Officer Dr. Robert Lanza to Deliver Opening Keynote Address at 4th Annual Stem Cell Symposium in Singapore
Sep 4, 2012 08:30:02 (ET)
MARLBOROUGH, Mass., Sep 04, 2012 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its chief scientific officer, Robert Lanza, M.D., will be delivering the opening Keynote Speech at the 4th Annual Stem Cell Symposium 2012, being held in Singapore, September 6-7. Dr. Lanza's presentation is titled "Pluripotent Stem Cells -- From Benchtop to Clinic."
With the theme, "Stem Cell Based Therapy," the symposium will have a particular focus on clinical trials and industrial application of stem cells. Sponsored by Stem Cell Society of Singapore (SCSS), the conference will include scientific presentations from key contributors from academic, clinical, and commercial organizations who are translating basic research on stem cells into therapeutics, with a focus on applying engineering technologies to provide medical solutions.
In their opening statement, the organizers state, "We are all keeping our 'fingers crossed' for ACT's success, which will also bring a big boost to the stem cell community."
Other topics of the conference include human induced pluripotent stem cells (hiPSCs), drug screening, adult and cancer stem cells, and stem cell therapies emerging from Asia, with presentations from Indian, Korean and Japanese regenerative medicine companies. There will also be a joint session with the International Society for Cellular Therapy (ISCT) covering important issues concerning the commercialization of stem cells, and addressing issues such as reimbursement, manufacturing, characterization, and clinical implementation issues unique to cell therapies.
Geron's CEO "Chip" will speak Wed at 10:55AM it will be webcast, should move the share price up or down. Geron has had a great run from $1.71 on Aug 17th to $2.76 today.
Good luck in this rigged casino,
No comments:
Post a Comment